Thomas Loughran, MD, reveals the most intriguing clinical applications for his LGL and acute myeloid leukemias research.
Category: Oncology Innovations (Page 2)
A novel neoadjuvant approach can essentially cure a disease that often gives patients a year or less to live.
UVA Health is among the first 25 centers to bring cancer patients the MRIdian Linac, a significant advance in MR-guided radiation therapy.
Find out what cutting-edge genomics technology uncovered as the critical drivers of gut-related cancers.
UVA Health is testing whether smartwatch-based preconditioning can improve abdominal cancer surgical outcomes.
See how UVA Health's lung cancer surgeons earned a coveted 3 stars from The Society of Thoracic Surgeons.
No other center has the depth of scientific knowledge & translational research know-how to produce more unprecedented results for rare hematologic malignancies.
Get practice-changing insight from UVA Cancer Center on methotrexate-based CNS prophylaxis for aggressive B-cell lymphoma.
A UVA Health researcher and colleagues have found that a new drug combination may lengthen survival in patients with advanced non-squamous NSCLC.
Discover the new worldwide leader in translational FUS immuno-oncology research.